BR112016015641A8 - composições e métodos de tratamento de condições patológicas inflamatórias da pele usando alantoína. - Google Patents

composições e métodos de tratamento de condições patológicas inflamatórias da pele usando alantoína.

Info

Publication number
BR112016015641A8
BR112016015641A8 BR112016015641A BR112016015641A BR112016015641A8 BR 112016015641 A8 BR112016015641 A8 BR 112016015641A8 BR 112016015641 A BR112016015641 A BR 112016015641A BR 112016015641 A BR112016015641 A BR 112016015641A BR 112016015641 A8 BR112016015641 A8 BR 112016015641A8
Authority
BR
Brazil
Prior art keywords
allantoin
skin
compositions
methods
pathological conditions
Prior art date
Application number
BR112016015641A
Other languages
English (en)
Other versions
BR112016015641A2 (pt
Inventor
Farber Elliott
Ryan Robert
Original Assignee
Scioderm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scioderm Inc filed Critical Scioderm Inc
Publication of BR112016015641A2 publication Critical patent/BR112016015641A2/pt
Publication of BR112016015641A8 publication Critical patent/BR112016015641A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BR112016015641A 2014-01-03 2014-01-03 composições e métodos de tratamento de condições patológicas inflamatórias da pele usando alantoína. BR112016015641A8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2014/010248 WO2015102642A1 (en) 2014-01-03 2014-01-03 Allantoin compositions for treating inflammatory skin conditions

Publications (2)

Publication Number Publication Date
BR112016015641A2 BR112016015641A2 (pt) 2017-10-03
BR112016015641A8 true BR112016015641A8 (pt) 2017-10-10

Family

ID=53493841

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016015641A BR112016015641A8 (pt) 2014-01-03 2014-01-03 composições e métodos de tratamento de condições patológicas inflamatórias da pele usando alantoína.

Country Status (7)

Country Link
EP (1) EP3089729A4 (pt)
JP (1) JP2017502053A (pt)
AU (1) AU2014374416A1 (pt)
BR (1) BR112016015641A8 (pt)
CA (1) CA2935836A1 (pt)
MX (1) MX2016008795A (pt)
WO (1) WO2015102642A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3086786A4 (en) * 2013-12-27 2017-06-14 Scioderm Inc. Keloid reduction using topical allantoin
GB201607814D0 (en) 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
CN109091478A (zh) * 2017-06-20 2018-12-28 中国医学科学院药物研究所 尿囊素在制备抗高尿酸血症和抗痛风药物中的应用
CN111246888A (zh) * 2017-10-20 2020-06-05 日本乐敦制药株式会社 皮肤障碍改善用组合物
CN111773212A (zh) * 2020-08-14 2020-10-16 云南中医药大学 一种瑞香素的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94806A0 (en) * 1990-06-20 1991-04-15 Ernest Bar On Pharmaceutical preparation containing thiol derivatives together with other active compounds
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US20060134149A1 (en) * 1999-07-23 2006-06-22 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US6281236B1 (en) * 1999-07-23 2001-08-28 Alwyn Company, Inc. Oil-in-water emulsion with improved stability
DE102004020890A1 (de) * 2004-03-26 2005-10-13 Wolf, Wilhelm R. Salbe zur Behandlung von oder Prophylaxe vor Nagelbettentzündung
EP2073794A2 (en) * 2006-11-14 2009-07-01 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US9629785B2 (en) * 2010-10-21 2017-04-25 Cadila Healthcare Limited Pharmaceutical compositions comprising nano size droplets of skin whitening agents
JP5769481B2 (ja) * 2011-04-15 2015-08-26 株式会社 資生堂 ウフェナマート含有皮膚外用剤
EP3086786A4 (en) * 2013-12-27 2017-06-14 Scioderm Inc. Keloid reduction using topical allantoin

Also Published As

Publication number Publication date
JP2017502053A (ja) 2017-01-19
EP3089729A1 (en) 2016-11-09
WO2015102642A1 (en) 2015-07-09
AU2014374416A1 (en) 2016-07-21
MX2016008795A (es) 2017-03-23
BR112016015641A2 (pt) 2017-10-03
CA2935836A1 (en) 2015-07-09
EP3089729A4 (en) 2017-06-14

Similar Documents

Publication Publication Date Title
HK1232141A1 (zh) 用於治療亨廷頓病的方法和組合物
DK3142637T3 (da) Keratin treatment formulations and methods
EP3188741A4 (en) Compositions and methods for the treating an inflammatory disease or disorder
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
BR112017011771A2 (pt) métodos e composições para o tratamento de câncer
BR112016023269A2 (pt) Tratamento de nafld e nash
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
BR112017024253A2 (pt) métodos de tratamento de inflamação ou dor neuropática.
DK3231444T3 (da) Ny behandling
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
BR112016022976A2 (pt) Métodos para o tratamento de hcv
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
DK3123381T3 (da) Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer
DK3110446T3 (da) Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme
DK3191103T3 (da) Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner
EP3137907A4 (en) Methods and compositions for the diagnosis and treatment of kawasaki disease
DK3122743T3 (da) Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme
BR112016015641A8 (pt) composições e métodos de tratamento de condições patológicas inflamatórias da pele usando alantoína.
GB201511207D0 (en) Isolated organ evaluation and treatment
BR112016015712A8 (pt) método de tratamento de doenças hepáticas.
BR112017011897A2 (pt) métodos de tratamento da fibrose
DK3580182T3 (da) Vandbehandling
DK3233104T3 (da) Immunterapi-behandlinger og -sammensætninger
GB201515244D0 (en) Treatment of inflammatory disease or condition
JP2016159244A5 (ja) 沈殿槽及び沈殿処理方法

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]